The role of statins on helicobacter pylori eradication : Results from the european registry on the management of h. pylori (hp-eureg)
Citation
Caldas , M , Pérez-Aisa , Á , Tepes , B , Keco-Huerga , A , Bujanda , L , Lucendo , A J , Rodrigo , L , Vaira , D , Fernández-Salazar , L , Huguet , J M , Pérez-Lasala , J , Jurecic , N B , Fadeenko , G , Barrio , J , Areia , M , Ortuño , J , Pellicano , R , Leja , M , Molina-Infante , J , Bogomolov , P , Alekseenko , S , Domínguez-Cajal , M , Gómez-Camarero , J , Ntouli , V , Martínez-Domínguez , S J , Ruiz-Zorrilla , R , Núñez , O , Silkanovna Sarsenbaeva , A , Almela , P , Phull , P , Espada , M , Puig , I , Nyssen , O P , Mégraud , F , O’Morain , C , Gisbert , J P & Hp-EuReg Investigators 2021 , ' The role of statins on helicobacter pylori eradication : Results from the european registry on the management of h. pylori (hp-eureg) ' , Antibiotics , vol. 10 , no. 8 , 965 . https://doi.org/10.3390/antibiotics10080965
Rights
Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/4.0/).